{
    "eid": "2-s2.0-84908025227",
    "title": "Cost-effectiveness of annual microalbuminuria screening in Thai diabetics",
    "cover-date": "2014-06-01",
    "subject-areas": [
        {
            "$": "General Biochemistry",
            "@code": "1300"
        },
        {
            "$": "General Medicine",
            "@code": "2700"
        }
    ],
    "keywords": [
        "Cost-effectiveness",
        "Diabetes",
        "Healthcare system",
        "Microalbuminuria",
        "Screenin"
    ],
    "authors": [
        "Attasit Srisubat"
    ],
    "citedby-count": 12,
    "ref-count": 36,
    "ref-list": [
        "Proteinuria in Diabetes",
        "Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial",
        "Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease",
        "Cost-effectiveness of using angiotensin-converting enzyme inhibitors to slow nephropathy in normotensive patients with diabetes type II and microalbuminuria",
        "Cost-effectiveness and socioeconomic implications of prevention and management of chronic kidney disease in type 2 diabetes",
        "Cost-Effective Strategies in the Prevention of Diabetic Nephropathy",
        "Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)",
        "Accuracy of urine dipstick test for microalbuminuria in type 2 diabetes mellitus patients.",
        "Cost-effectiveness of two screening programs for microalbuminuria in type 2 diabetes.",
        "Thailand Info [Internet]",
        "Annual Report of Thai Universal Health Coverage Scheme 2009",
        "Comparison of quality of life and causes of hospitalization between hemodialysis and peritoneal dialysis patients in China",
        "Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: A post hoc analysis of the RENAAL trial results",
        "Clinical Guidelines and Evidence Review for Type 2 Diabetes Renal Disease: Prevention and Early Management",
        "An introduction to Markov modelling for economic evaluation",
        "Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes",
        "Public Health Statistics 2010 [Internet]",
        "The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes",
        "Thailand diabetic registry cohort: Predicting death in Thai diabetic patients and causes of death",
        "Methods for the Economic Evaluation of Health Care Programmes",
        "Estimating population-based values for EQ-5D health states in Thailand",
        "Choosing Interventions that are Cost-effective (WHO-CHOICE): Costeffectiveness Thresholds [Internet]",
        "GDP per Capita (Current US$)",
        "Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease",
        "Value Health",
        "Preference-based quality of life of patients on renal replacement therapy: A systematic review and meta-analysis",
        "Assessing a Societal Value for a Ceiling Threshold in Thailand",
        "Health economic modelling of the cost-effectiveness of microalbuminuria screening in Switzerland",
        "Cost-effectiveness of screening and early treatment of nephropathy in patients with insulin-dependent diabetes mellitus",
        "Screening to prevent renal failure in insulin dependent diabetic patients: An economic evaluation",
        "A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA",
        "Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes",
        "Screening for Proteinuria in US Adults: A Cost-effectiveness Analysis",
        "Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: A modeled analysis",
        "Should all Pima Indians with type 2 diabetes mellitus be prescribed routine angiotensin-converting enzyme inhibition therapy to prevent renal failure?",
        "The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ministry of Public Health"
    ]
}